Importer of Controlled Substances Application: AMRI Rensselaer, Inc., 35692 [2019-15737]
Download as PDF
<![CDATA[
35692
Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices
The company plans to import the
listed controlled substance in bulk for
manufacture of analytical reference
material which, in its final form, is an
exempted product.
Dated: July 15, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–15738 Filed 7–23–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: AMRI Rensselaer, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 23, 2019. Such persons
may also file a written request for a
hearing on the application on or before
August 23, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
DATES:
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.34(a), this is notice that on May 7,
2019, AMRI Rensselaer, Inc., 33
Riverside Avenue, Rensselaer, New
York 12144 applied to be registered as
an importer of the following basic class
of controlled substance:
Controlled substance
Drug code
Poppy Straw
Concentrate.
9670
Schedule
II
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Drug Enforcement Administration Bulk
Manufacturer of Controlled
Substances Application: IsoSciences,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 23, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
The company plans to import the
listed controlled substance to
manufacture a bulk controlled substance
for distribution to its customers.
Dated: July 15, 2019.
John J. Martin,
Assistant Administrator.
In accordance with 21 CFR
1301.33(a), this is notice that on May 21,
2019, IsoSciences, LLC, 340 Mathers
Road, Ambler, Pennsylvania 19002–
3420 applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
[FR Doc. 2019–15737 Filed 7–23–19; 8:45 am]
BILLING CODE 4410–09–P
Drug
code
khammond on DSKBBV9HB2PROD with NOTICES
Controlled substance
Cathinone ................................................................................................................................................................................
Methcathinone .........................................................................................................................................................................
Lysergic acid diethylamide ......................................................................................................................................................
Marihuana ................................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .........................................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................................
Bufotenine ................................................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................................
Psilocybin .................................................................................................................................................................................
Psilocyn ...................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .....................................................................................................................................
Dihydromorphine .....................................................................................................................................................................
Heroin ......................................................................................................................................................................................
Nicocodeine .............................................................................................................................................................................
Nicomorphine ...........................................................................................................................................................................
Normorphine ............................................................................................................................................................................
Thebacon .................................................................................................................................................................................
Normethadone .........................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .........................................................................................
Para-Fluorofentanyl .................................................................................................................................................................
3-Methylfentanyl ......................................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ...............................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................................
Butyryl Fentanyl .......................................................................................................................................................................
VerDate Sep<11>2014
16:53 Jul 23, 2019
Jkt 247001
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
E:\FR\FM\24JYN1.SGM
24JYN1
1235
1237
7315
7360
7370
7400
7404
7405
7431
7432
7433
7434
7435
7437
7438
7439
9145
9200
9309
9312
9313
9315
9635
9811
9812
9813
9814
9815
9816
9821
9822
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 84, Number 142 (Wednesday, July 24, 2019)]
[Notices]
[Page 35692]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15737]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: AMRI Rensselaer,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before August 23, 2019.
Such persons may also file a written request for a hearing on the
application on or before August 23, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on May 7,
2019, AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York
12144 applied to be registered as an importer of the following basic
class of controlled substance:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Poppy Straw Concentrate............ 9670 II
------------------------------------------------------------------------
The company plans to import the listed controlled substance to
manufacture a bulk controlled substance for distribution to its
customers.
Dated: July 15, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-15737 Filed 7-23-19; 8:45 am]
BILLING CODE 4410-09-P
